Data / Form D filings / Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc.: Form D filings
Mirum Pharmaceuticals, Inc., a biotechnology company in Foster City, CA, filed 3 Form D notices with the SEC between 2018 and 2026. The latest, on January 29, 2026, reports $68.5 million sold of a $68.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, Foster City, CA, 94404
- Phone
- (650) 667-4085
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1759425
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | New notice | $68,480,000 | $68,480,000 | 2 | Jan 23, 2026 | sec.gov | |
| Dec 30, 2020 | New notice | $10,000,000 | $10,000,000 | 3 | Dec 22, 2020 | sec.gov | |
| Nov 20, 2018 | New notice | $120,063,750 | $60,063,750 | $60,000,000 | 14 | Nov 5, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Peetz | Executive Officer, Director | |
| Eric Bjerkholt | Executive Officer | |
| Peter Radovich | Executive Officer | |
| Laura Brege | Director | |
| Timothy Walbert | Director | |
| William C. Fairey | Director | |
| Patrick Heron | Director | |
| Lon Cardon | Director | |
| Saira Ramasastry | Director | |
| Laurent Fischer | Director | |
| Michael Grey | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 26, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mirum Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.